Next, we overexpressed GATA2 plasmid DNA in the two neuroblastoma cell lines and measured cell viability in response to #5333 and #5338 treatment but were unable to show a reduced drug effect on cell viability in the presence of excess GATA2 (Supplementary Figure S5A–F). The gene discussed is GATA2; the disease is neuroblastoma.